Acute stent thrombosis in a patient with giant cell arteritis

Jason Andrade1, Abdullah Al Ali, Jacqueline Saw

  • 1Division of Cardiology, University of British Columbia, Vancouver General Hospital, Vancouver.

Insights

Giant cell arteritis can cause acute stent thrombosis in patients with myocardial infarction, even with dual antiplatelet therapy. This case suggests prolonged, aggressive antiplatelet therapy may be needed for acute coronary syndromes in inflammatory conditions.

Area of Science:

  • Cardiology
  • Rheumatology
  • Pharmacology

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis primarily affecting large and medium-sized arteries.
  • Non-ST elevation myocardial infarction (NSTEMI) requires prompt revascularization and antiplatelet therapy.

Observation:

  • A 70-year-old man with NSTEMI and suspected GCA developed acute stent thrombosis 70 hours post-percutaneous coronary intervention (PCI) despite dual antiplatelet therapy.
  • Platelet aggregometry revealed reduced responsiveness to clopidogrel, which improved as GCA symptoms resolved with prednisone treatment.

Findings:

  • This is the first reported case of acute stent thrombosis associated with GCA.
  • The pro-inflammatory state in GCA may impair the efficacy of standard antiplatelet agents like clopidogrel.

Implications:

  • Patients with acute coronary syndromes and concurrent inflammatory conditions like GCA may require more aggressive or prolonged antiplatelet strategies.
  • Further research is warranted to explore the interaction between systemic inflammation and antiplatelet therapy response in cardiovascular patients.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...